The present application relates to the technical field of medical devices, and in particular to an integrated ablation needle and an ablation system.
With the development of minimally invasive medical technology, ablation has been widely used in the treatment of diseases such as liver, kidney and soft tissue tumors. In an ablation procedure, a radiofrequency ablation needle or microwave ablation needle is usually inserted into the lesion site to provide high temperature for the local tissue at the lesion site with radiofrequency energy or microwave energy to cause coagulation necrosis of the tissue, thereby treating the disease. In order to get the effect of the ablation treatment, it is necessary to take out the tissue sample for pathological analysis, i.e., biopsy, after the ablation is completed.
In the prior arts, the ablation needle and the biopsy needle are usually separated. The ablation needle usually first punctures into the diseased tissue to perform ablation, and after the ablation is completed, the ablation needle is withdrawn from the human body. After that, the biopsy needle then individually punctures into the ablated tissue to perform sampling. This means two punctures are required for the ablation and the biopsy after ablation. Puncturing repeatedly increases the damage to the human body's tissues and organs, increases the potential operative risk and extends the operation time.
In view of the above, the present application provides an integrated ablation needle and an ablation system, in which the ablation and the biopsy are integrated on the same ablation needle, thereby avoiding puncturing repeatedly, reducing the damage to the human body, and saving the operation time.
In order to solve the above technical problems, the present application provides an integrated ablation needle, which comprises a sleeve and an electrode needle movably inserted in the sleeve. The electrode needle comprises a needle tip at a distal end and a needle bar connected to a proximal end of the needle tip. The needle bar has a sampling slot at least at a portion of the needle bar near the needle tip. A distal end of the sleeve is provided with a cutting portion. The sleeve is axially movable relative to the needle bar to expose or cover the sampling slot. When the sampling slot is exposed, tissue around the needle bar enters the sampling slot. When the sampling slot is covered, the cutting portion cuts the tissue inside the sampling slot off from the tissue outside the sampling slot to obtain the tissue in the sampling slot as a biopsy sample.
The present application further provides an ablation system comprising the aforementioned integrated ablation needle and an energy generating device electrically connected to the electrode needle of the integrated ablation needle.
In the integrated ablation needle and the ablation system according to the present application, the integrated ablation needle comprises a sleeve and an electrode needle movably inserted into the sleeve, a sampling slot is opened on the needle bar of the electrode needle, and the distal end of the sleeve is provided with a cutting portion. The electrode needle is electrically connected to the energy generating device for performing ablation. After ablation, the sleeve is movable proximally to expose the sampling slot, so that tissue around the needle bar can enter the sampling slot, and the sleeve is movable distally to cover the sampling slot, so that the cutting portion of the sleeve at the distal end thereof can cut the tissue inside the sampling slot off from the tissue outside the sampling slot, thereby obtaining the tissue in the sampling slot as a biopsy sample. Therefore, that ablation and the biopsy are integrated on the integrated ablation needle, with no need for a separate biopsy operation, thereby avoiding puncturing repeatedly, reducing the damage to the human body, and saving the operation time.
In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings accompanying the embodiments will be briefly described below, and it will be apparent that the drawings in the following description are some embodiments of the present application, for those skilled in the art, other drawings can be obtained from the drawings without creative labor.
The technical solutions according to the embodiments of the present application will be clearly and fully described below with reference to the drawings accompanying the embodiments of the present application. Apparently, the described embodiments are only part of, instead of all of the embodiments of the present application. All other embodiments obtained by the skilled person according to the embodiments disclosed in the present application without creative labor fall into the protection scope of the present application.
In the description of the present application, it should be noted that terms denoting the orientation or positional relationships, such as “above”, “below”, “inner”, “outer”, refer to the orientation or positional relationships shown in the drawings for convenience of description, but not indicating or implying that the device or element referred to must have the particular orientation or be constructed and operated in the particular orientation, and thus cannot be construed as limiting the present application. In addition, terms such as “the first” and “the second” are used for descriptive purpose only and are not to be understood as indicating or implying relative importance.
In the description of the present application, it should be noted that in the field of interventional medical devices, the proximal end refers to the end closer to the operator, the distal end refers to the end far away from the operator, and the axial direction refers to the direction parallel to the line connecting the center of the distal end and the center of the proximal end of the medical device in the natural state. These terms are for convenience of description only and are not to be construed as limiting the present application.
Referring to
Specifically, referring to
Referring to
In other embodiments, the sampling slot 231 can include a plurality of long narrow grooves extending along the axial direction of the needle bar 23, and the plurality of long narrow grooves can be spaced apart from each other in the circumferential or axial direction of the needle bar 23.
In other embodiments, the sampling slot 231 can include one or a plurality of arc grooves extending along the circumferential direction of the needle bar 23, and the plurality of arc grooves are spaced apart from each other in the circumferential or axial direction of the needle bar 23.
In other embodiments, the sampling slot 231 can include one or a plurality of annular grooves extending one round along the circumferential direction of the needle bar 23, and the plurality of annular grooves are spaced apart from each other in the axial direction of the needle bar 23.
Referring to
Specifically, as shown in
As described above, the proximal end of the sleeve 10 is fixedly connected with the driving mechanism in the handle 30, and the needle bar 23 is movably received in the sleeve 10, so that the sleeve 10 can be moved relative to the needle bar 23 in the axial direction by moving the driving mechanism in the handle 30 in the axial direction, thereby exposing or covering the sampling slot 231 in the needle bar 23 as required. Specifically, in some embodiments, as the driving mechanism within the handle 30 is moved proximally a certain distance, the handle 30 moves the sleeve 10 proximally until the sampling slot 231 is exposed, as shown in
Optionally, the sleeve 10 is provided with a first positioning portion, and the electrode needle 20 is provided with a second positioning portion. The first positioning portion is configured to be engaged with the second positioning portion to achieve the axial positioning between the electrode needle 20 and the sleeve 10, thereby indicating whether the sampling slot 231 is completely covered, so that the situation that the sampling slot 231 is not completely covered and thus the tissue inside the sampling slot 231 is not completely cut off from the tissue outside the sampling slot 231 can be avoided.
Specifically, as shown in
In other embodiments, the first positioning portion and the second positioning portion can be a first developing point and a second developing point, respectively, which can be developed under a medical imaging device. The first developing point is provided on the outer peripheral surface or the inner peripheral surface of the sleeve 10 at the distal end thereof close to the cutting portion 11 of the sleeve 10 at the distal end thereof. The second developing point is provided on the outer peripheral surface of the connecting section 213 of the needle tip 21 close to the sampling slot 213. The operator determines whether or not the sampling slot 231 is completely covered by observing the relative position between the first developing point and the second developing point under the medical imaging device. When the first developing point and the second developing point coincide or partially coincide, it can be determined that the sampling slot 231 is completely covered. Furthermore, the first developing point and the second developing point can help the operator to determine whether the distal end of the electrode needle 20 reaches or is located at a predetermined ablation location.
The first developing point and the second developing point can be developed by, for example, ultrasonic development or X-ray fluoroscopy, and preferably by ultrasonic development which is less harmful to human body, with lower cost.
It can be understood that, by driving the sleeve 10 to move axially relative to the needle bar 23 through the driving mechanism in the handle 30, not only the sampling slot 231 can be exposed or covered, the length of the distal end of the electrode needle 20 extending out of the sleeve 10 can also be adjusted, thereby changing the effective ablation length of the integrated ablation needle 100 to meet the ablation requirements at different lesion sites or different patients.
The sleeve 10 surrounding the electrode needle 20 is at least partially insulated, that is, the sleeve 10 can be completely insulated or partially insulated. In the case where the sleeve 10 is completely insulated, the portion of the electrode needle 20 at the distal end thereof extending out of the sleeve 10 performs ablation, and the length of the portion of the electrode needle 20 at the distal end thereof extending out of the sleeve 10 is the effective ablation length of the integrated ablation needle 100. In the case where the sleeve 10 is partially insulated, the portion of the electrode needle 20 at the distal end thereof extending out of the sleeve 10 and the non-insulated portion of the sleeve 10 perform ablation, the effective ablation length of the integrated ablation needle 100 is the sum of the length of the portion of the electrode needle 20 at the distal end thereof extending out of the sleeve 10 and the length of the non-insulated portion of the sleeve 10. Preferably, in this embodiment, the sleeve 10 is completely insulated. The entirety of the sleeve 10 can be made of an insulating material, for example, a plastic tube such as PEEL, PI or PA that meets the hardness requirements, or a ceramic tube such as alumina porcelain, steatite porcelain, or boron nitride. The entirely of the sleeve 10 can be made of a non-insulated material, and the outer surface of the sleeve 10 is covered with an insulating coating. In this embodiment, in order to improve the rigidity of the sleeve 10 and facilitate the puncturing of the sleeve 10 into human tissue, preferably, the sleeve 10 is made of a metal material, and the outer surface of the tube of the sleeve 10 is coated with an insulating coating. The metal material includes, but is not limited to, 304 stainless steel, 321 stainless steel, or 631 stainless steel. The insulating coating includes, but is not limited to, PTFE coating, titanium nitride coating, parylene coating, or the like. The metal material of which the sleeve 10 is made should have sufficient hardness to puncture into human tissue, as well as excellent biocompatibility. The insulating coating should have reliable insulation and excellent biocompatibility, with a small coefficient of friction. Further, the insulating coating needs to be closely bonded with the outer surface of the tube of the sleeve 10, and is not easy to peel off. For example, a 304 stainless steel tube with PTFE coating, a 304 stainless steel tube with parylene coating, a 321 stainless steel tube with titanium nitride coating, or a 631 stainless steel tube with parylene coating can be used. Considering the insulation reliability and the process feasibility, the thickness of any kind of the insulating coatings should be no smaller than 3 μm.
It can be conceived that, in other embodiments, the sleeve 10 can be partially insulated, and the non-insulated portion of the sleeve 10 can be used to transmit high frequency current or microwave so as to enlarge the ablation area.
Referring to
Specifically, as shown in
As shown in
Further, in order to prevent the leakage of the cooling medium from the radial gap between the sleeve 10 and the needle bar 23 during ablation, a sealing mechanism is provided on the sleeve 10 and/or the needle bar 23 to seal the radial gap between the sleeve 10 and the needle bar 23, and when the sampling slot 231 is closed by the sleeve 10, the sealing mechanism is located between the sampling slot 231 and the needle tip 21. Specifically, referring to
In other embodiments, a plurality of sealing grooves 235 can be axially defined in a portion of the needle bar 23 adjacent to the needle tip 21, and each of the sealing grooves 235 is provided with a sealing ring 60 to enhance the sealing effect.
Referring to
The ablation system 1000 further includes the cooling medium supplying device 300 that communicates with the vacuum device 40 of the integrated ablation needle 100 through a pair of circulating tubes 45 and thus communicates with the cooling channel 233 of the electrode needle 20 to provide sufficient cooling medium in a gaseous or liquid state into the cooling channel 233 for controlling the temperature of the integrated ablation needle 100 during ablation.
Referring to
In the first step, as shown in
In the second step, after the ablation is completed, the cooling medium supplying device 300 is closed, the vacuum device 40 is opened, and the cooling medium is completely sucked out by negative pressure effect. After the cooling medium is completely discharged by the vacuum device 40, the handle 30 is operated to drive the sleeve 10 connected therewith to move proximally relative to the needle bar 23 of the electrode needle 20 to completely or partially expose the sampling slot 231. The ablated tissue around the needle bar 23 will partially enter the sampling slot 231 and the vacuum device 40, which is still working, will provide a negative pressure on the tissue, causing the tissue to be drawn into the sampling slot 231, as shown in
In the third step, the handle 30 is operated to drive the sleeve 10 to move distally relative to the needle bar 23 of the electrode needle 20, until the sampling slot 231 is completely covered. The tissue inside the sampling slot 231 is cut off from the tissue outside the sampling slot 231 by the cutting portion 11 of the sleeve 10 at the distal end thereof, so that the tissue within the sampling slot 231 is separated from other tissue and retained within the sampling slot 231, as shown in
The integrated ablation needle 100 and the ablation system 1000 according to the present application integrate the ablation and the biopsy on the same ablation needle, with no need to perform a separate biopsy step, thereby avoiding puncturing repeatedly, reducing the damage to the human body, and reducing the potential operative risk and saving the operation time.
Referring to
In order to ensure the sharpness of the cutting surface 113b during cutting, in this embodiment, the second angle β preferably ranges from 25 degrees to 35 degrees.
Referring to
Specifically, in use of the integrated ablation needle 100c, the outer tube 70 surrounds the sleeve 10 and is punctured into the diseased tissue together with the sleeve 10 and the electrode needle 20. Prior to ablation, the outer tube 70 is moved axially proximally relative to the sleeve 10 and the electrode needle 20 to expose the distal portions of the sleeve 10 and the electrode needle 20 that are assembled together; and after that, the sleeve 10 is moved axially relative to the electrode needle 20 to obtain a pre-ablation tissue sample, the sleeve 10 and the electrode needle 20 assembled together are then withdrawn outside of the human body from the outer tube 70, with the outer tube 70 remained in the tissue, and the pre-ablation tissue sample in the sampling slot 231 of the electrode needle 20 is taken out. After that, the sleeve 10 and the electrode needle 20 assembled together enter the lesion site of the diseased tissue via the outer tube 70 retained in the tissue as a passage to perform ablation. After ablation, the sleeve 10 is moved axially relative to the electrode needle 20 again to obtain the ablated tissue sample. Finally, the outer tube 70, the sleeve 10 and the electrode needle 20 are withdrawn from the human body together.
In order to avoid excessive resistance during puncture due to an excessively large outer diameter of the integrated ablation needle 100c due to the outer tube 70, in this embodiment, the proximal end of the needle tip 21 is provided with an avoidance groove 237 around the circumference thereof. The second annular step 25 is formed at the junction of the avoidance groove 237 and the sealing groove 235 in the needle bar 23. When the sleeve 10 is axially positioned with respect to the electrode needle 20, the first annular step 14 (not shown) of the sleeve 10 abuts against the second annular step 25, and the cutting portion 11 of the sleeve 10 is received in the avoidance groove 237. The outer diameter of the sleeve 10 is equal to or smaller than the diameter of the proximal end of the needle tip 21, so that the outer diameter of the integrated ablation needle 100c does not increase after the outer tube 70 surrounds the sleeve 10, which facilitates the puncturing. In addition, the cutting portion 11 of the sleeve 10 is received in the avoidance groove 237, so that the cutting portion 11 of the sleeve 10 can be protected.
Preferably, the distal end of the outer tube 70 is provided with an inclined surface 71 which is closer to the axis of the outer tube 70 from the proximal end to the distal end thereof for reducing the resistance to the outer tube 70 entering the tissue, which facilitates the puncturing.
In this embodiment, the outer tube 70 is added to the outside of the sleeve 10 and can be inserted into the tissue together with the sleeve 10 and the electrode needle 20, and then the outer tube 70 can be retained in the tissue as a passage for pre-ablation biopsy, ablation and post-ablation biopsy, thereby avoiding puncturing repeatedly, reducing the damage to the human body, and reducing the potential operative risk and saving the operation time.
It should be noted that modifications and developments made to the above embodiment of the present application by those skilled in the art without departing from the principles of the embodiments of the present application fall in the protection scope of this application.
Number | Date | Country | Kind |
---|---|---|---|
201911424501.1 | Dec 2019 | CN | national |
201922501255.7 | Dec 2019 | CN | national |
This application is a continuation of International Application No. PCT/CN2020/130917 filed on Nov. 23, 2020, which claims the priority of Chinese Patent Application No. 201911424501.1, filed on Dec. 31, 2019, and priority of Chinese Patent Application No. 201922501255.7, filed on Dec. 31, 2019, the disclosure of which are incorporated herein by reference in their entities.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/CN2020/130917 | Nov 2020 | US |
Child | 17850798 | US |